Source comparison
How to Use Peptides for Addiction Recovery: Protocol Comparison
The table below compares the three most researched peptides for addiction recovery based on mechanism, dosing structure, clinical evidence quality, and realistic outcome expectations. Cerebrolysin BDNF/NGF-mediated synaptogenesis in reward pathways 10–30ml IM,
This comparison does not assign a generated winner or score.
- The table below compares the three most researched peptides for addiction recovery based on mechanism, dosing structure, clinical evidence quality, and realistic outcome expectations.
- Cerebrolysin
- BDNF/NGF-mediated synaptogenesis in reward pathways
- 10–30ml IM, 3× weekly, 4–6 week cycles
- Moderate. RCTs in methamphetamine and alcohol dependence
- Craving reduction noticeable by week 3–4; measurable receptor upregulation by week 6–8
- Best-supported compound for stimulant and alcohol addiction; requires IM administration
- Dihexa
- HGF receptor activation. Synaptic density amplification
- 1–3mg SubQ daily, 8–12 week cycles
- Low. Animal models only; no Phase III human addiction trials
- Cognitive clarity improvement by week 4–5; neuroplasticity gains slower than Cerebrolysin
- Promising for dopamine pathway repair but lacks direct addiction-focused clinical validation
- Thymalin
- Thymic peptide. Immune normalization, reduces neuroinflammation
- 10mg SubQ daily × 10 days, then 3–4 month rest
- Low. Primarily studied for immune senescence, not addiction
- Inflammation markers reduce by day 7–10; indirect neuroplasticity support only
- Adjunct compound. Addresses inflammatory barrier to recovery but not a standalone solution